ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-9 |

Results: 9

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction

Authors: Willette, RN Anderson, KM Nelson, AH Olzinski, AR Woods, T Coatney, RW Aiyar, N Ohlstein, EH Barone, FC

Citation: Rn. Willette et al., Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction, J CARDIO PH, 38(4), 2001, pp. 606-617

Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction

Authors: Behr, TM Nerurkar, SS Nelson, AH Coatney, RW Woods, TN Sulpizio, A Chandra, S Brooks, DP Kumar, S Lee, JC Ohlstein, EH Angermann, CE Adams, JL Sisko, J Sackner-Bernstein, JD Willette, RN

Citation: Tm. Behr et al., Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction, CIRCULATION, 104(11), 2001, pp. 1292-1298

Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats

Authors: Barone, FC Coatney, RW Chandra, S Sarkar, SK Nelson, AH Contino, LC Brooks, DP Campbell, WG Ohlstein, EH Willette, RN

Citation: Fc. Barone et al., Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats, CARDIO RES, 50(3), 2001, pp. 525-537

Meniscal ossification in spontaneous osteoarthritis in the guinea-pig

Authors: Kapadia, RD Badger, AM Levin, JM Swift, B Bhattacharyya, A Dodds, RA Coatney, RW Lark, MW

Citation: Rd. Kapadia et al., Meniscal ossification in spontaneous osteoarthritis in the guinea-pig, OSTEO CART, 8(5), 2000, pp. 374-377

Human urotensin-II is a potent vasoactive peptide: Pharmacological characterization in the rat, mouse, dog and primate

Authors: Douglas, SA Ashton, DJ Sauermelch, CF Coatney, RW Ohlstein, DH Ruffolo, MR Ohlstein, EH Aiyar, NV Willette, RN

Citation: Sa. Douglas et al., Human urotensin-II is a potent vasoactive peptide: Pharmacological characterization in the rat, mouse, dog and primate, J CARDIO PH, 36, 2000, pp. S163-S166

Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure

Authors: Behr, TM Wang, XK Aiyar, N Coatney, RW Li, X Koster, P Angermann, CE Ohlstein, E Feuerstein, GZ Winaver, J

Citation: Tm. Behr et al., Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure, CIRCULATION, 102(11), 2000, pp. 1315-1322

Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia

Authors: Chandra, S White, RF Everding, D Feuerstein, GZ Coatney, RW Sarkar, SK Barone, FC

Citation: S. Chandra et al., Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia, PHARMACOL, 58(6), 1999, pp. 292-299

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999)

Authors: Ames, RS Sarau, HM Chambers, JK Willette, RN Alyar, NV Romanic, AM Louden, CS Foley, JJ Sauermelch, CF Coatney, RW Ao, ZH Disa, J Holmes, SD Stadel, JM Martin, JD Liu, WS Glover, GI Wilson, S McNulty, DE Ellis, CE Elshourbagy, NA Shabon, U Trill, JJ Hay, DWP Ohlstein, EH Bergsma, DJ Douglas, SA

Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999), NATURE, 402(6764), 1999, pp. 898-898

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

Citation: Rs. Ames et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, NATURE, 401(6750), 1999, pp. 282-286

Risultati: 1-9 |